// App-Quantinova.ai

19105 : Basis for Biochemical Discordance Between Activated Partial Thromboplastin Time and Anti-factor Xa in Patients with Continuous Flow Left Ventricular Assist Device on Unfractionated Heparin Infusion

Researchers

Presenter

  • Amy J Feng

Principal Investigators

  • Chadi M Alraies

  • Thenappan Thenappan

  • Monica Colvin

  • Ranjit John

  • Peter Eckman

  • Marc Pritzker

  • Sirtaz Adatya

Medical Centers

  • University of Minnesota, Minneapolis, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Coagulation Factor III, Tissue Factor

  • Lactate dehydrogenase

Drug/Treatment

  • Heparin

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved